Use este identificador para citar ou linkar para este item: http://hdl.handle.net/1843/63455
Tipo: Artigo de Periódico
Título: Sulfonamide-functionalized polymeric nanoparticles for enhanced in vivo colorectal cancer therapy
Autor(es): Pedro Pires Goulart Guimarães
Celso Tarso Rodrigues Viana
Luciana Xavier Pereira
Sávio Morato Lacerda Gontijo
Paula Peixoto Campos
Silvia Passos Andrade
Robson Augusto Souza dos Santos
Rubén Dario Sinisterra Millán
Resumo: Background: Colorectal cancer (CRC) is the third most common cancer in the world. 5- Fluorouracil (5-FU) is a conventional and most effective drug used in the clinic for the treatment of CRC. However, the clinical use of 5-FU is limited due to the acquired resistance and systemic toxicity, such as hepatotoxicity and gastrointestinal toxicity. Objective: Recent advances in nanomedicine are being exploited to develop nanoparticle platforms to overcome resistance and therapeutic delivery of active molecules. Here, we developed 5-FU loaded sulfadiazine-poly(lactide-co-glycolide) nanoparticles (SUL-PLGA NPs) to be applied in the colorectal cancer model. Methods: We assessed the in vivo efficacy of the SUL-PLGA NPs to enhance the antitumor effect of 5-FU. Results: In vivo treatment with 5-FU-SUL-PLGA NPs significantly reduced tumor growth in a colon cancer xenograft model compared to free 5-FU and 5-FU loaded non-targeted NPs. Treatment with 5-FU-SUL-PLGA NPs also increased blood vessel diameters within tumors, which could act in conjunction to enhance antitumor efficacy. In addition, 5-FU-SUL-PLGA NPs significantly reduced liver mass and lung mass, which are the most common metastasis sites of CRC, and decreased liver hepatotoxicity compared to free 5-FU drug and 5-FU loaded non-targeted NPs. Conclusion: Our findings suggest that the use of 5-FU-SUL-PLGA NPs is a promising strategy to enhance 5-FU efficacy against CRC.
Assunto: Nanopartículas
Câncer - Tratamento
Cólon (Anatomia) - Câncer
Sistema de distribuição de medicamentos
Sistemas deliberados de drogas poliméricas
Ácidos sulfônicos
Idioma: eng
País: Brasil
Editor: Universidade Federal de Minas Gerais
Sigla da Instituição: UFMG
Departamento: FAO - DEPARTAMENTO DE ODONTOLOGIA RESTAURADORA
ICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICA
ICB - DEPARTAMENTO DE PATOLOGIA
ICX - DEPARTAMENTO DE QUÍMICA
Tipo de Acesso: Acesso Restrito
Identificador DOI: https://doi.org/10.2174/1567201818666210729110127
URI: http://hdl.handle.net/1843/63455
Data do documento: 2022
metadata.dc.url.externa: https://www.eurekaselect.com/article/116952
metadata.dc.relation.ispartof: Current Drug Delivery
Aparece nas coleções:Artigo de Periódico

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.